{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:59:22Z","timestamp":1790884762202,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["201540306"],"award-info":[{"award-number":["201540306"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81303192"],"award-info":[{"award-number":["81303192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005201","name":"Elsevier Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.intimp.2017.03.029","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T09:34:53Z","timestamp":1491471293000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"special_numbering":"C","title":["Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-\u043aB\/I\u043aB\u03b1, p38 MAPK, and Bcl-2\/Bax signaling"],"prefix":"10.1016","volume":"47","author":[{"given":"Rong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2017.03.029_bb0005","first-page":"644","article-title":"Decreased expression of p38 MAPK mediates protective effects of hydrogen sulfide on hepatic fibrosis","volume":"17","author":"Fan","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2017.03.029_bb0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/aps.2014.41","article-title":"Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis","volume":"35","author":"Li","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2017.03.029_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jep.2012.09.048","article-title":"Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-\u03baB\/I\u03baB\u03b1 signaling","volume":"144","author":"Wang","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jep.2015.03.024","article-title":"Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe","volume":"166","author":"Yang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jep.2013.05.031","article-title":"Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components","volume":"148","author":"Yang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0030","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/bjophthalmol-2012-301537","article-title":"Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy","volume":"96","author":"Yoon","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0035","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1211\/0022357021396","article-title":"The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats","volume":"55","author":"Lee","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0040","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1440-1746.2012.07262.x","article-title":"Quercetin improves hepatic fibrosis reducing hepatic stellate cells and regulating pro-fibrogenic\/anti-fibrogenic molecules balance","volume":"27","author":"Hern\u00e1ndez-Ortega","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0045","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3945\/jn.109.105353","article-title":"Quercetin administration ameliorates pulmonary complications of cirrhosis in rats","volume":"139","author":"Tieppo","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.intimp.2017.03.029_bb0050","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/jgh.12147","article-title":"Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-\u03baB pathway in activated stellate cells: in vivo and in vitro studies","volume":"28","author":"Kong","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver-linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1478-3231.2004.00900.x","article-title":"A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis","volume":"24","author":"Bruck","year":"2004","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2017.03.029_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jat.1249","article-title":"Resveratrol prevents fibrosis, NF-\u03baB activation and TGF-\u03b2 increases induced by chronic CCl4 treatment in rats","volume":"28","author":"Ch\u00e1vez","year":"2008","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jat.1393","article-title":"NF-\u03baB in liver diseases: a target for drug therapy","volume":"29","author":"Muriel","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","article-title":"Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine","volume":"6","author":"Walker","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2017.03.029_bb0080","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.bcp.2004.07.016","article-title":"Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats","volume":"68","author":"Moreira","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0085","first-page":"681","article-title":"Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells - up regulation of Nrf2 expression and down regulation of NF-\u03baB and COX-2","volume":"2014","author":"Ramyaa","year":"1840","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2017.03.029_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.cr.7290257","article-title":"Activation and signaling of the p38 MAP kinase pathway","volume":"15","author":"Zarubin","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2017.03.029_bb0095","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm1388","article-title":"Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells","volume":"12","author":"Ito","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2017.03.029_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2015.12.024","article-title":"Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1\/Nrf2-mediated inhibition of p38 MAPK pathway","volume":"292","author":"Gu","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0105","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1074\/jbc.272.21.13829","article-title":"Nonionic detergents induce dimerization among members of the Bcl-2 family","volume":"272","author":"Hsu","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2017.03.029_bb0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2017.03.029_bb0115","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/jpet.103.060129","article-title":"The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse","volume":"308","author":"Canbay","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2017.03.029_bb0120","first-page":"6303","article-title":"Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-\u03baB\/I\u03baB\u03b1, and Bcl-2\/Bax signaling","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2017.03.029_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jep.2010.06.020","article-title":"Effects of sodium houttuyfonate on expression of NF-\u03baB and MCP-1 in membranous glomerulonephritis","volume":"131","author":"Pan","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2006-927387","article-title":"Mouse models of liver fibrosis","volume":"45","author":"Weiler-Normann","year":"2007","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0135","first-page":"633","article-title":"Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury","volume":"311","author":"Slater","year":"1985","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.intimp.2017.03.029_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/br.2016.681","article-title":"Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis","volume":"5","author":"Tang","year":"2016","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.intimp.2017.03.029_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jep.2015.12.053","article-title":"Hepatoprotective effects of Dicliptera chinensis polysaccharides on dimethylnitrosamine-induced hepatic fibrosis rats and its underlying mechanism","volume":"179","author":"Zhang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0150","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/CS20090549","article-title":"Role of nuclear factor \u03baB in liver health and disease","volume":"118","author":"Robinson","year":"2010","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.intimp.2017.03.029_bb0155","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.4049\/jimmunol.178.11.7097","article-title":"Genome-wide analysis of gene expression in T cells to identify targets of the NF-\u03baB transcription factor c-Rel","volume":"178","author":"Bunting","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0160","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.taap.2012.04.012","article-title":"New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage","volume":"261","author":"Hamdy","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0165","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/IAI.01412-06","volume":"75","author":"Olson","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2017.03.029_bb0170","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.biocel.2006.03.023","article-title":"NFkappaB pathway: a good signaling paradigm and therapeutic target","volume":"38","author":"Tergaonkar","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0175","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/emboj\/cdg139","article-title":"Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)","volume":"22","author":"Vermeulen","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2017.03.029_bb0180","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3748\/wjg.v12.i9.1392","article-title":"Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells","volume":"12","author":"Zhang","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphar.2014.00167","article-title":"The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies","volume":"5","author":"Xu","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2017.03.029_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jphs.2015.12.002","article-title":"Ameliorative effects of tannic acid on carbon tetrachloride-induced liver fibrosis in vivo and in vitro","volume":"130","author":"Chu","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2017.03.029_bb0200","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2005.082701","article-title":"Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans","volume":"55","author":"Novo","year":"2006","journal-title":"Gut"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917301303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917301303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:07:20Z","timestamp":1761584840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917301303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":40,"alternative-id":["S1567576917301303"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.03.029","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-\u043aB\/I\u043aB\u03b1, p38 MAPK, and Bcl-2\/Bax signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}